Factors predicting maintenance of sinus rhythm after direct current cardioversion of atrial fibrillation and flutter: A reanalysis with recently acquired data?

Cardiology (Switzerland)

Volumn 87, Issue 3, 1996, Pages 181-188

  Amar, David O ^a   Danielsen, Ragnar ^a  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Atrial arrhythmias; Cardioversion; Chest; Direct current; Echocardiography; X ray

Indexed keywords

AGED; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART SIZE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINUS RHYTHM; THORAX RADIOGRAPHY; VALVULAR HEART DISEASE;

EID: 0029872013     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000177084     Document Type: Article

References (38)

1. Kanncl WB. Abbott RD. Savage DD. McNamara PM: Epidemiologie features of chronic a trial fibrillation: The Framingham study. N Engl J Med 1982:306:1018-1022.
2. Brand FN, Abbott RD, Kännel WB, Wolf PA: Characteristics and prognosis of lone a trial fibrillation: 30 year follow up in the Framingham study. JAMA 1985:254:3449-3453.
3. Wolf PA. Abbott RD. Kännel WB: A trial fibrillation: A major contributor to stroke in the elderly. The Framingham study. Arch Intern Med 1987:147:1561-1564.
4. Hillcstad L. Bjcrkclund C. Dale J. Maltau J. Storstein O: Quinidine in the maintenance of sinus rhythm after electroconversion of chronic a trial fibrillation. Br Heart J 1971:33:518-521.
5. Södermark T. Jonsson B. Olsson A. Orö L. Wallin H, Edltag O, Sjögren A, Daniclsson M. Roscnhamer G: Effect of quinidine in maintaining sinus rhythm after conversion of a trial fibrillation and flutter. Br Heart J 1975;37: 486-492.
6. Coplen SE. Amman EM. Berlin JA. Hewitt P. Chalmers TC: Efficacy of quinidine therapy for maintenance of sinus rhythm after cardioversion. Circulation 1990:82:1106-1116.
7. Van Gelder IC. Crijns H. Van Gilst WH. Ver-wer R. Lie Kl: Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct current electrical cardioversion of chronic a trial fibrillation and Butter. Am J Cardiol 1991:68:41-46.
8. Dittrich HC. Erickson JS. Schneiderman T, Blacky AR, Savides T. Nicod PH: Echocardiographie and clinical predictors for outcome of elective cardioversion of a trial fibrillation. Am J Cardiol 1989:63:193-197.
9. Ewy G, Ulfers L. Hager W. Rosenfeldt AR. Roeskc WR. Goldman S: Response of a trial fibrillation to therapy: Role of etiology and left a trial diameter. J Electrocardiol 1980:13:119-124.
10. Henry WL. Morganroth J. Pearlman AS, Clark CE. Redwood DR, Itscoitz SB. Epstein SE: Relation between echocardiographicallv determined left a trial size and a trial fibrillation. Circulation 1976:53:273-279.
11. Flugeiman MY. Hasin Y, Katznelson N. Kri-wisky M. Shefer A. Gotsman MS: Restoration and maintenance of sinus rhythm after mitral valve surgery for mitral stenosis. Am J Cardiol 1984:54:617-619.
12. Hoglund C. Rosenhamer G: Echocardiographie left a trial dimension as a predictor of maintaining sinus rhythm after cardioversion of a trial fibrillation. Acta Med Stand 1985:217: 411-415.
13. Bjcrkclund C. Orning OM: An evaluation of DC shock treatment of a trial arrhythmias. Acta Med Scan 1968; 184:481-491.
14. Morris JJ. Peter RH, McIntosh HD: Electrical conversion of a trial fibrillation. Ann Intern Med 1966;65:216-231.
15. Waris E, Krcus KE. Salokancncl J: Factors influencing persistence of sinus rhythm after DC shock treatment of a trial fibrillation. Acta MedScand 1971:189:161-166.
16. Lundström T. Ryden L: Chronic a trial fibrillation. Long-term results of direct current cardioversion. Acta Med Scand 1988:233:53-59.
17. Ewy GA: Direct current shock and transcardiac impedance. Am J Cardiol 1980:45:909.
18. Ewy GA. Taren D: Impedance to transthoracic direct current discharge: A model for testing interface material. Med Instrum 1978:12:47-48.
19. DeSilva RA. Graboys TTS, Podrod PJ, Lown B: Cardioversion and defibrillation. Am Heart J 1980:100:881-895.
20. Kerber RE. Martins JB, Kelley KJ, Ferguson DW. Kouba C. Jensen SR. Newman B. Parke JD. Kieso R. Melton J: Self adhesive preapplied electrode pads for defibrillation and cardioversion. J Am Coll Cardiol 1984:3:815-820.
21. Halpcrn SW. Ellrodt G. Singh BN. Mandel WJ: Efficacy of intravenous procainamide infusion in converting a trial fibrillation to sinus rhythm. Br Heart J 1980;44:589-595.
22. Brodsky MA, Allen BJ, Capparelli EV. Luckctt CR. Morton R. Henry WL: Factors determining maintenance of sinus rhythm after chronic a trial fibrillation with left a trial dilatation. Am J Cardiol 1989:63:1065-1068.
23. Brodsky MA, Allen BJ. Walker CJ III. Casey TP. Casey TP. lucketl CR. Henry WL: Amio-daronc for maintenance of sinus rhythm after conversion of a trial fibrillation in the setting of a dilated left atrium. Am J Cardiol 1987;60: 572-575.
24. Juul-Moller S, Edvardsson N, Rehnquist-Ahl-berg N: Sotalol versus quinidine for maintenance of sinus rhythm after direct current cardioversion of a trial fibrillation. Circulation 1990;82:1932-1939.
25. The National Heart. Lung, and Blood Institute Working Group on A trial Fibrillation: A trial fibrillation: Current understanding and research imperatives. J Am Coll Cardiol 1993:22: 1830-1834.
26. Reimold SC. Cantilion CO, Friedman PL. Ant-man EM: Propafenone versus sotalol for suppression of recurrent symptomatic a trial fibrillation. Am J Cardiol 1993:71:558-563.
27. Graboys TB. Podrid PJ. Lown B: Efficacy of amiodaronc for refractory supraventricular tachyarrhythmias. Am Heart J 1983; 106:870-876.
28. Disch DL. Greenberg ML. Holzbcrger PT. Malenka DJ. Birkmcycr JD: Managing chronic a trial fibrillation: A Markov decision analysis comparing warfarin, quinidine and low dose amiodarone. Ann Intern Med 1994:120:449-457.
29. Petersen P. Gottfredsen J. Boysen G. Andersen ED. Andersen B: Placebo controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic a trial fibrillation: The Copenhagen AFASAK study. Lancet 1589:i: 175-179.
30. The Boston Area Anticoagulation Trial for A trial Fibrillation Investigators: The effect of low dose warfarin on the risk of stroke in patients with nonrheumatic a trial fibrillation. N Engl J Med 1990:323:1505-1511.
31. Connolly SJ. Laupacis A. Gent M. Roberts RS, Cairns JA. Hoyner C, for the CAFA study coin-vestigators: Canadian A trial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991:18:349-355.
32. Stroke prevention in a trial fibrillation investigators. Stroke prevention in a trial fibrillation study: Final results. Circulation 1991:84:527-539.
33. Ezekowilz MD. Bridgcrs SL, James KE. Carliner NIL Colling CL. Comick CC, Krausc-Stcinrauf H. Kurtzke JF. Nazarian SM. Radford MJ. Rickies FR. Shabetai R. Dcvkin D: Warfarin in the prevention of stroke associated with nonrheumatic a trial fibrillation. N Engl J Med 1992:327:1406-1412.
34. Stroke Prevention in A trial Fibrillation Investigators: Warfarin versus aspirin for prevention of thromboembolism in a trial fibrillation. Stroke prevention in a trial fibrillation II study. Lancet 1994:343:687-691.
35. Klein HO, Kaplinsky E: Verapamil and digox-in: Their respective effects on a trial fibrillation and their interaction. Am J Cardiol 1982:50: 894-902.
36. Williamson BD, Man KC. Daood E. Niebauer M, Strickberger AS, Morady F: Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during a trial fibrillation. N Engl J Med 1994:331: 910-917.
37. Cox JL: The surgical treatment of a trial fibrillation. IV. Surgical technique. J Thorac Cardio-vascSurg 1991:101:584-592.
38. Powell AC, Garan H. McGovern BA, Fallon JT. Krishnan SC, Ruskin JN: Low energy conversion of a trial fibrillation in the sheep. J Am Coll Cardiol 1992;20:707-711.